Trial leadership

Map & ranking Research output

Publication counts reward volume. This index rewards presence in the evidence that changed practice: the trials, products, and technologies recorded in OnCo that an institution or cooperative group is linked to. It is disclosed, simple, and only as complete as the corpus.

score = 3 × linked trials + 2 × linked products + linked technologies + linked targets, counting distinct OnCo objects connected in either direction. Cooperative groups (SWOG, NRG, Alliance, BIG…) are included because they, not single hospitals, run most academic phase 3 trials. To move an institution up, document the trial it led and link it.

#	Institution	Trials	Products	Technologies	Targets	Score
1	Cancer Research UK London, GB	29 · ABC-02, ABC-07, ACT II +26 more	-	1	0	88
2	University College London Hospitals / UCL Cancer Institute London, GB	21 · ABC-07, ABC-12, EUROPAC +18 more	-	9	0	72
3	National Cancer Institute (NIH) Bethesda, MD, US	20 · ALCHEMIST, Alliance/CALGB 50303, CALGB 40603 +17 more	-	8	0	68
4	Tata Memorial Centre Mumbai, IN	16 · Add-Aspirin, Elective vs therapeutic neck dissection in node-negative oral cancer, Gefitinib vs gefitinib plus pemetrexed-carboplatin in EGFR-mutant lung cancer +13 more	1 · Talicabtagene autoleucel	3	0	53
5	The Royal Marsden London, GB	11 · ABC-07, c-TRAK TN, InterAACT +8 more	2 · Abiraterone acetate, Olaparib	2	0	39
6	The Institute of Cancer Research London, GB	10 · CHHiP, FAST, IMPORT LOW +7 more	3 · Abiraterone acetate, Capivasertib, Olaparib	0	0	36
7	MD Anderson Cancer Center Houston, US	7 · ADIUVO-2, Gemcitabine, cisplatin and nab-paclitaxel phase 2, GETUG 13 +4 more	-	8	0	29
8	Oxford Cancer (Oxford University Hospitals and University of Oxford) Oxford, GB	6 · FOCUS4, MRC COIN, Precision-Panc +3 more	1 · Tebentafusp	5	1	26
9	Memorial Sloan Kettering Cancer Center New York, US	4 · Autogene cevumeran phase 1 in resected pancreatic cancer, AZUR-1, Beat AML Master Trial +1 more	1 · Dostarlimab	12	0	26
10	University Hospitals Birmingham / University of Birmingham Cancer Research Centre Birmingham, GB	7 · FOxTROT, National Lung Matrix Trial, New EPOC +4 more	-	3	0	24
11	Gustave Roussy Villejuif, FR	6 · ESTIMABL2, FIRSTMAPPP, Inter-B-NHL Ritux 2010 +3 more	2 · Datopotamab deruxtecan, Trastuzumab deruxtecan	2	0	24
12	The Christie NHS Foundation Trust Manchester, GB	6 · ABC-12, CONVERT, DETERMINE +3 more	-	4	0	22
13	UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, US	5 · I-SPY 1, I-SPY 2, I-SPY 2.2 +2 more	1 · Gallium-68 gozetotide	3	2	22
14	Leeds Cancer Centre, St James's University Hospital Leeds, GB	6 · EUROPAC, FOxTROT, MRC CR07 +3 more	-	3	0	21
15	Dana-Farber Brigham Cancer Center Boston, US	5 · BWEL, Cemiplimab for kidney transplant recipients with advanced skin squamous cell carcinoma, DETERMINATION +2 more	1 · NeoVax	4	0	21
16	Charité Universitätsmedizin Berlin Berlin, DE	5 · CONKO-001, CONKO-003, CONKO-005 +2 more	-	5	0	20
17	Society of Gynecologic Oncology Chicago, IL, US	5 · KEYNOTE-A18 / ENGOT-cx11 / GOG-3047, LACC, NRG-GY018 / KEYNOTE-868 +2 more	-	5	0	20
18	Shanghai Chest Hospital Shanghai, CN	2 · ALTER 0303, FURLONG	4 · Amivantamab, Ivonescimab, Lorlatinib +1 more	2	4	20
19	West German Cancer Center (WTZ), University Hospital Essen Essen, DE	2 · CheckMate 067, VISION	4 · Ipilimumab, Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan +1 more	5	0	19
20	Guangdong Provincial People's Hospital Guangzhou, CN	2 · ADAURA, FLAURA2	3 · Erlotinib, Gefitinib, Osimertinib	3	3	18
21	Karolinska University Hospital Stockholm, SE	5 · ALASCCA, NORPACT-1, ScreenTrustCAD +2 more	-	2	0	17
22	National Cancer Center Hospital Tokyo, JP	4 · ALTAIR, CIRCULATE-Japan, ROMANA 1 and ROMANA 2 +1 more	2 · Datopotamab deruxtecan, Trastuzumab deruxtecan	1	0	17
23	Netherlands Cancer Institute (NKI-AvL) Amsterdam, NL	4 · NADINA, Netherlands Cancer Institute HIPEC trial, NICHE-2 +1 more	1 · Tacquell	3	0	17
24	Erasmus MC Cancer Institute Rotterdam, NL	3 · PREOPANC-2, PREOPANC-3, TESLA RCT	1 · Lutetium-177 dotatate	5	1	17
25	Guy's and St Thomas' NHS Foundation Trust / King's Health Partners Cancer Centre London, GB	3 · NHS-Galleri, OlympiA, VIOLET	2 · Galleri, Olaparib	4	0	17
26	International Agency for Research on Cancer (IARC / WHO) Lyon, FR	3 · IARC India HPV vaccine dose study, Kerala oral cancer visual screening trial, Osmanabad cervical screening trial	1 · CERVAVAC	6	0	17
27	Massachusetts General Hospital Cancer Center Boston, US	3 · INTUITT-NF2, NCI-MATCH, PARTIQoL	-	8	0	17
28	Georgetown Lombardi Comprehensive Cancer Center Washington, DC, US	1 · CLEOPATRA	3 · Docetaxel, Pertuzumab, Trastuzumab	6	2	17
29	UCLA Jonsson Comprehensive Cancer Center Los Angeles, US	2 · GBM AGILE, PSMA-PreRP	3 · Gallium-68 gozetotide, Palbociclib, Trastuzumab	2	2	16
30	SIOP Europe (European Society for Paediatric Oncology) Brussels, BE	5 · EURAMOS-1, Euro Ewing 2012, Inter-B-NHL Ritux 2010 +2 more	-	0	0	15
31	The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute Columbus, OH, US	2 · Beat AML Master Trial, RESONATE	2 · Acalabrutinib, Ibrutinib	3	2	15
32	Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, IT	1 · CheckMate 067	3 · Ipilimumab, Nivolumab, Relatlimab + nivolumab	3	3	15
33	Newcastle Cancer Centre / Northern Centre for Cancer Care Newcastle upon Tyne, GB	3 · CAPP2, EUROPAC, Precision-Panc	-	3	2	14
34	UC San Diego Moores Cancer Center La Jolla, CA, US	2 · I-PREDICT, WINTHER	2 · Dinutuximab (ch14.18) / dinutuximab beta, Zilovertamab vedotin	2	2	14
35	Heidelberg University Hospital / NCT / DKFZ Heidelberg, DE	1 · NOA-08	-	9	2	14
36	National Cancer Center Hospital East Kashiwa, Chiba, JP	-	2 · Nivolumab, Trastuzumab deruxtecan	6	4	14
37	Velindre Cancer Centre Cardiff, GB	3 · MRC COIN, SCC-AFTER, SPOT-IT	-	4	0	13
38	Advanced Centre for Treatment, Research and Education in Cancer Navi Mumbai, IN	1 · Talicabtagene autoleucel (NexCAR19) phase 1/2	2 · Nivolumab, Talicabtagene autoleucel	5	1	13
39	Peking University Cancer Hospital Beijing, CN	1 · CT041-ST-01	2 · Disitamab vedotin, Satricabtagene autoleucel	3	3	13
40	Winship Cancer Institute of Emory University Atlanta, GA, US	1 · RxPONDER	3 · Daratumumab, Oncotype DX, Osimertinib	2	2	13
41	Society of Nuclear Medicine and Molecular Imaging Reston, VA, US	-	3 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Piflufolastat F-18 / Pylarify TruVu	7	0	13
42	Stanford Health Care / Stanford Cancer Institute Stanford, US	-	-	12	1	13
43	Addenbrooke's Hospital, Cambridge University Hospitals Cambridge, GB	4 · BILCAP, MoleMate UK Trial, PARTNER +1 more	-	0	0	12
44	Imperial College Healthcare NHS Trust / Imperial College London Cancer Research London, GB	4 · Precision-Panc, PROMIS, TRANSFORM +1 more	-	0	0	12
45	Liverpool University Hospitals HPB centre (Aintree) Liverpool, GB	4 · ESPAC-3, ESPAC-4, ESPAC-5 +1 more	-	0	0	12
46	Nottingham University Hospitals Cancer Centre (City Hospital) Nottingham, GB	4 · EUROPAC, Nottingham faecal occult blood screening trial, Precision-Panc +1 more	-	0	0	12
47	Beatson West of Scotland Cancer Centre / CRUK Scotland Institute Glasgow, GB	2 · Precision-Panc, SCOT	-	4	2	12
48	National Medical Products Administration / Center for Drug Evaluation Beijing, CN	1 · ORIENT-11	3 · Disitamab vedotin, Ivonescimab, Mecapegfilgrastim	3	0	12
49	National Taiwan University Hospital Taipei, TW	-	3 · Afatinib, Atezolizumab, Osimertinib	3	3	12
50	University of Colorado Cancer Center Aurora, CO, US	-	4 · Crizotinib, Entrectinib, Larotrectinib +1 more	1	3	12
51	Sun Yat-sen University Cancer Center Guangzhou, CN	3 · CAPTAIN-1st, CONTINUUM, JUPITER-02	1 · Izalontamab brengitecan	0	0	11
52	Vall d'Hebron University Hospital / VHIO Barcelona, ES	3 · DESTINY-Breast03, DESTINY-Breast09, WINTHER	1 · Encorafenib	0	0	11
53	University Hospital Southampton / Centre for Cancer Immunology Southampton, GB	2 · EUROPAC, Precision-Panc	-	4	1	11
54	Fudan University Shanghai Cancer Center Shanghai, CN	1 · FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer	1 · FDA018-ADC	5	1	11
55	Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center Baltimore, US	1 · ECLIPSE	1 · Pembrolizumab	6	0	11
56	Sheba Medical Center Ramat Gan, IL	1 · WINTHER	1 · Olaparib	4	2	11
57	Children's Hospital of Philadelphia Philadelphia, PA, US	-	3 · Crizotinib, Lorlatinib, Tisagenlecleucel	3	2	11
58	Multinational Association of Supportive Care in Cancer Aurora, ON, CA	-	-	11	0	11
59	UPMC Hillman Cancer Center Pittsburgh, PA, US	-	3 · Cetuximab, Relatlimab + nivolumab, Tamoxifen	4	1	11
60	Cancer Research UK Manchester Institute Manchester, GB	2 · DETERMINE, TARGET National	-	4	0	10
61	Jilin Cancer Hospital Changchun, CN	2 · ASTRUM-005, CAPSTONE-1	2 · Adebrelimab, Serplulimab	0	0	10
62	Peter MacCallum Cancer Centre Melbourne, AU	2 · proPSMA, TheraP	1 · Lutetium-177 vipivotide tetraxetan	2	0	10
63	St. Jude Children's Research Hospital Memphis, TN, US	2 · Childhood Cancer Survivor Study, SJMB12	-	4	0	10
64	Hadassah Medical Center Jerusalem, IL	1 · HBI0101 (NXC-201) multiple myeloma phase 1	-	4	3	10
65	Mayo Clinic Rochester, MN, US	1 · Gemcitabine, cisplatin and nab-paclitaxel phase 2	-	7	0	10
66	Comprehensive Cancer Center Mainfranken, University Hospital Würzburg Würzburg, DE	-	2 · Ciltacabtagene autoleucel, Teclistamab	4	2	10
67	Hospital Universitario 12 de Octubre Madrid, ES	-	2 · Durvalumab, Tarlatamab	4	2	10
68	Inselspital, Bern University Hospital / University Cancer Center Inselspital Bern, CH	-	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	4	2	10
69	Istituto di Candiolo IRCCS (FPO) Candiolo, IT	-	1 · Trastuzumab	4	4	10
70	OHSU Knight Cancer Institute Portland, OR, US	1 · Beat AML Master Trial	1 · Imatinib	3	1	9
71	Tongji Hospital, Huazhong University of Science and Technology Wuhan, CN	1 · FUMANBA-1	1 · Equecabtagene autoleucel	4	0	9
72	Abramson Cancer Center, University of Pennsylvania Philadelphia, US	-	-	7	2	9
73	European Association of Nuclear Medicine Vienna, AT	-	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	5	0	9
74	Huntsman Cancer Institute, University of Utah Salt Lake City, UT, US	-	2 · Enzalutamide, Talazoparib	4	1	9
75	IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola Bologna, IT	-	2 · Glofitamab, Teclistamab	3	2	9
76	IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) Meldola, IT	-	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	3	2	9
77	NCI Center for Cancer Research (intramural programme) Bethesda, MD, US	-	1 · Aldesleukin	5	2	9
78	TUM Klinikum rechts der Isar / CCC München Munich, DE	-	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	5	0	9
79	University Hospital Düsseldorf / CIO Düsseldorf Düsseldorf, DE	-	2 · FAP-2286, Lutetium-177 vipivotide tetraxetan	3	2	9
80	University Hospital Zurich / Comprehensive Cancer Center Zurich Zurich, CH	-	2 · Optune / Optune Pax, Talimogene laherparepvec	5	0	9
81	Cancer Research UK Cambridge Centre / CRUK Cambridge Institute Cambridge, GB	1 · PARTNER	-	5	0	8
82	Indian Institute of Technology Bombay Mumbai, IN	1 · Talicabtagene autoleucel (NexCAR19) phase 1/2	1 · Talicabtagene autoleucel	2	1	8
83	National Cancer Center Korea Goyang, KR	1 · KLASS-01	-	5	0	8
84	Oslo University Hospital, The Norwegian Radium Hospital Oslo, NO	1 · NORPACT-1	-	5	0	8
85	University of Florida Health Cancer Center Gainesville, FL, US	1 · ICONIC: ivermectin combined with immune checkpoint inhibition in cancer	1 · Ivermectin	3	0	8
86	All India Institute of Medical Sciences, New Delhi New Delhi, IN	-	-	8	0	8
87	BC Cancer Vancouver, BC, CA	-	1 · Brentuximab vedotin	6	0	8
88	Chulabhorn Hospital / Chulabhorn Royal Academy Bangkok, TH	-	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	4	0	8
89	Dartmouth Cancer Center Lebanon, NH, US	-	2 · Ipilimumab, Nivolumab	2	2	8
90	Institut Jules Bordet Brussels, BE	-	2 · Pembrolizumab, Trastuzumab	4	0	8
91	IRCCS Humanitas Research Hospital Rozzano (Milan), IT	-	2 · Atezolizumab, Durvalumab	4	0	8
92	IUCT Oncopole (Institut Universitaire du Cancer de Toulouse) Toulouse, FR	-	2 · Ciltacabtagene autoleucel, Teclistamab	4	0	8
93	Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, NY, US	-	1 · Nivolumab	4	2	8
94	National Cancer Centre Singapore Singapore, SG	-	-	5	3	8
95	Postgraduate Institute of Medical Education and Research, Chandigarh Chandigarh, IN	-	2 · Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan	4	0	8
96	Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, IL, US	-	2 · Optune / Optune Pax, Temozolomide	4	0	8
97	Ruijin Hospital, Shanghai Jiao Tong University Shanghai, CN	-	2 · Arsenic trioxide, Tretinoin	4	0	8
98	Stephenson Cancer Center, OU Health Oklahoma City, OK, US	-	2 · Mirvetuximab soravtansine, Olaparib	2	2	8
99	Sunnybrook Odette Cancer Centre Toronto, ON, CA	-	-	8	0	8
100	University of Wisconsin Carbone Cancer Center Madison, WI, US	-	1 · Dinutuximab (ch14.18) / dinutuximab beta	5	1	8
101	Asan Medical Center Seoul, KR	2 · DEBATE, NIFTY	-	1	0	7
102	IEO (European Institute of Oncology) Milan, IT	2 · Milan I, SOUND	-	1	0	7
103	Cancer Hospital, Chinese Academy of Medical Sciences Beijing, CN	1 · DAWNA-1	2 · Disitamab vedotin, Sacituzumab tirumotecan	0	0	7
104	Cancer Institute (WIA), Adyar Chennai, IN	1 · IARC India HPV vaccine dose study	-	4	0	7
105	Cedars-Sinai Cancer Los Angeles, CA, US	1 · Ivermectin with balstilimab or pembrolizumab in metastatic triple-negative breast cancer	1 · Ivermectin	2	0	7
106	Comprehensive Cancer Center Freiburg (CCCF) Freiburg im Breisgau, DE	1 · MATRix/IELSG43	-	4	0	7
107	Frederick National Laboratory for Cancer Research Frederick, MD, US	1 · NCI-MATCH	-	3	1	7
108	Leiden University Medical Center Leiden, NL	1 · RAINBO	-	4	0	7
109	Mays Cancer Center at UT Health San Antonio San Antonio, TX, US	1 · Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma	2 · Gemcitabine, Ruxolitinib	0	0	7
110	Narayana Health (Mazumdar Shaw Medical Centre) Bengaluru, IN	1 · IMAGINE	1 · Varnimcabtagene autoleucel	2	0	7
111	Rosalind and Morris Goodman Cancer Institute, McGill University Montréal, QC, CA	1 · WINTHER	-	2	2	7
112	Society of Surgical Oncology Rosemont, IL, US	1 · MSLT-II	-	4	0	7
113	Centre hospitalier de l'Université de Montréal (CHUM) Montréal, QC, CA	-	2 · Abiraterone acetate, Olaparib	3	0	7
114	Comprehensive Cancer Center Vienna, Medical University of Vienna / AKH Vienna, AT	-	1 · Palbociclib	5	0	7
115	Instituto Alexander Fleming Buenos Aires, AR	-	2 · Palbociclib, Trastuzumab	1	2	7
116	IRCCS Ospedale San Raffaele Milan, IT	-	1 · Trastuzumab	4	1	7
117	Kyoto University Hospital Kyoto, JP	-	1 · Nivolumab	3	2	7
118	Purdue Institute for Cancer Research West Lafayette, IN, US	-	1 · Lutetium-177 vipivotide tetraxetan	3	2	7
119	Seoul St. Mary's Hospital Seoul, KR	-	2 · Imatinib, Nilotinib	3	0	7
120	Shanghai Pulmonary Hospital Shanghai, CN	-	-	4	3	7
121	Uppsala University Hospital / Uppsala University Uppsala, SE	-	1 · Lutetium-177 dotatate	4	1	7
122	UZ Leuven / Leuven Cancer Institute Leuven, BE	-	-	5	2	7
123	Weizmann Institute of Science Rehovot, IL	-	-	4	3	7
124	Bristol Haematology and Oncology Centre Bristol, GB	2 · EUROPAC, ProtecT	-	0	0	6
125	Derriford Hospital, University Hospitals Plymouth Plymouth, GB	2 · BILCAP, EUROPAC	-	0	0	6
126	Glasgow Royal Infirmary Glasgow, GB	2 · EUROPAC, Precision-Panc	-	0	0	6
127	Krankenhaus Nordwest / Institute of Clinical Cancer Research (IKF) Frankfurt am Main, DE	2 · FLOT4-AIO, GAIN	-	0	0	6
128	Medical College of Wisconsin Cancer Center Milwaukee, WI, US	2 · BMT CTN 0803, BMT CTN 1102	-	0	0	6
129	Barts Cancer Institute / Barts Health NHS Trust London, GB	1 · STARPAC2	-	3	0	6
130	Montefiore Einstein Comprehensive Cancer Center Bronx, NY, US	1 · TAILORx	1 · Oncotype DX	1	0	6
131	Sarcoma Oncology Center Santa Monica, US	1 · Aldoxorubicin versus investigator's choice in relapsed or refractory soft tissue sarcoma	1 · Aldoxorubicin	1	0	6
132	American Society for Radiation Oncology Arlington, VA, US	-	-	6	0	6
133	Apollo Hospitals (Apollo Cancer Centres) Chennai, IN	-	-	6	0	6
134	Central Drugs Standard Control Organization New Delhi, IN	-	2 · Imatinib, Trastuzumab	2	0	6
135	Centro Nacional de Investigaciones Oncológicas (CNIO) Madrid, ES	-	-	4	2	6
136	Cleveland Clinic Taussig Cancer Institute Cleveland, US	-	-	6	0	6
137	Comprehensive Cancer Center Tübingen-Stuttgart Tübingen, DE	-	1 · Afamitresgene autoleucel	4	0	6
138	European Society for Radiotherapy and Oncology Brussels, BE	-	-	6	0	6
139	Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Dallas, TX, US	-	1 · Belzutifan	3	1	6
140	Holden Comprehensive Cancer Center, University of Iowa Iowa City, IA, US	-	1 · Lutetium-177 dotatate	3	1	6
141	Hospital Clínic de Barcelona / IDIBAPS Barcelona, ES	-	-	4	2	6
142	Hospital del Mar / Hospital del Mar Research Institute Barcelona, ES	-	1 · Trastuzumab	3	1	6
143	Institute of Oncology Ljubljana Ljubljana, SI	-	1 · Carboplatin	4	0	6
144	Lausanne University Hospital (CHUV) / Ludwig Institute Lausanne Lausanne, CH	-	1 · Pembrolizumab	4	0	6
145	Mayo Clinic Comprehensive Cancer Center in Florida Jacksonville, FL, US	-	-	4	2	6
146	nationales Netzwerk Genomische Medizin Lungenkrebs Cologne, DE	-	-	0	6	6
147	NCT/UCC Dresden, University Hospital Carl Gustav Carus Dresden, DE	-	-	6	0	6
148	Pharmaceuticals and Medical Devices Agency Tokyo, JP	-	2 · Osimertinib, Trastuzumab deruxtecan	2	0	6
149	Society for Immunotherapy of Cancer Milwaukee, WI, US	-	-	6	0	6
150	Taipei Veterans General Hospital Taipei, TW	-	-	6	0	6
151	Walter and Eliza Hall Institute of Medical Research Melbourne, AU	-	1 · Venetoclax	3	1	6
152	Wellcome Sanger Institute Hinxton, GB	-	-	5	1	6
153	Zhongshan Hospital, Fudan University Shanghai, CN	-	-	3	3	6
154	FDA Oncology Center of Excellence Silver Spring, MD, US	1 · ORIENT-11	-	2	0	5
155	Histiocyte Society Pitman, US	1 · LCH-III	1 · Vinblastine	0	0	5
156	Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi Varanasi, IN	1 · METRO PLUS	-	2	0	5
157	The Francis Crick Institute London, GB	1 · TRACERx	-	2	0	5
158	Yale Cancer Center / Smilow Cancer Hospital New Haven, CT, US	1 · NCI-MATCH	-	1	1	5
159	Aarhus University Hospital Aarhus, DK	-	-	5	0	5
160	Cancer Center Clínica Universidad de Navarra / CIMA Pamplona, ES	-	-	5	0	5
161	Chinese PLA General Hospital Beijing, CN	-	-	4	1	5
162	Chinese Society of Clinical Oncology Beijing, CN	-	1 · Ivonescimab	3	0	5
163	Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine Houston, TX, US	-	-	4	1	5
164	David H. Koch Institute for Integrative Cancer Research at MIT Cambridge, MA, US	-	-	3	2	5
165	Department of Biotechnology, Government of India New Delhi, IN	-	1 · CERVAVAC	3	0	5
166	Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, IN, US	-	1 · Cisplatin	3	0	5
167	Instituto Nacional de Cancerología (Mexico) Mexico City, MX	-	-	5	0	5
168	Instituto Português de Oncologia do Porto Francisco Gentil Porto, PT	-	-	4	1	5
169	International Association for the Study of Lung Cancer Denver, CO, US	-	-	5	0	5
170	IRCCS Regina Elena National Cancer Institute Rome, IT	-	-	4	1	5
171	Istituto Oncologico Veneto IRCCS Padua, IT	-	1 · Trastuzumab	3	0	5
172	Kenyatta National Hospital Nairobi, KE	-	-	5	0	5
173	King Faisal Specialist Hospital and Research Centre Riyadh, SA	-	-	5	0	5
174	King Hussein Cancer Center Amman, JO	-	-	5	0	5
175	Lagos University Teaching Hospital Lagos, NG	-	-	4	1	5
176	Masaryk Memorial Cancer Institute Brno, CZ	-	-	4	1	5
177	Princess Máxima Center for Pediatric Oncology Utrecht, NL	-	-	5	0	5
178	Renji Hospital, Shanghai Jiao Tong University Shanghai, CN	-	2 · Satricabtagene autoleucel, Zevorcabtagene autoleucel	1	0	5
179	Severance Hospital, Yonsei University Seoul, KR	-	-	5	0	5
180	Shandong Cancer Hospital and Institute Jinan, CN	-	-	5	0	5
181	Shizuoka Cancer Center Nagaizumi, Shizuoka, JP	-	-	5	0	5
182	Siteman Cancer Center, Washington University St. Louis, MO, US	-	-	5	0	5
183	Sydney Children's Hospitals Network / Children's Cancer Institute Sydney, AU	-	-	5	0	5
184	UMC Utrecht Cancer Center Utrecht, NL	-	-	5	0	5
185	Union Hospital, Tongji Medical College Wuhan, CN	-	-	3	2	5
186	University Cancer Center Mainz (UCT Mainz) / Universitätsmedizin Mainz Mainz, DE	-	1 · Autogene cevumeran	3	0	5
187	University of Chicago Medicine Comprehensive Cancer Center Chicago, IL, US	-	-	3	2	5
188	University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore, MD, US	-	-	5	0	5
189	Vanderbilt-Ingram Cancer Center Nashville, TN, US	-	1 · Osimertinib	1	2	5
190	Amsterdam UMC / Cancer Center Amsterdam Amsterdam, NL	1 · COLOPEC	-	1	0	4
191	Bowel Cancer UK London, GB	1 · TRACC	-	1	0	4
192	Liverpool Heart and Chest Hospital NHS Foundation Trust Liverpool, GB	1 · UKLS	-	1	0	4
193	LMU Klinikum München Munich, DE	1 · TRIANGLE	-	1	0	4
194	Mount Vernon Cancer Centre Northwood, GB	1 · CHART	-	1	0	4
195	Ninewells Hospital, Dundee Dundee, GB	1 · Precision-Panc	-	1	0	4
196	Roy Castle Lung Cancer Foundation Liverpool, GB	1 · UKLS	-	1	0	4
197	A.C. Camargo Cancer Center São Paulo, BR	-	-	3	1	4
198	Butaro Cancer Center of Excellence Butaro, RW	-	-	4	0	4
199	Centre Antoine Lacassagne Nice, FR	-	-	4	0	4
200	Champalimaud Foundation, Champalimaud Clinical Centre Lisbon, PT	-	-	4	0	4
201	Chang Gung Memorial Hospital Taoyuan, TW	-	-	4	0	4
202	Charlotte Maxeke Johannesburg Academic Hospital / University of the Witwatersrand Johannesburg, ZA	-	-	4	0	4
203	Children's Cancer Hospital Egypt 57357 Cairo, EG	-	-	4	0	4
204	Chris O'Brien Lifehouse Sydney, AU	-	-	4	0	4
205	Christian Medical College, Vellore Vellore, IN	-	-	4	0	4
206	Cleveland Clinic Abu Dhabi Abu Dhabi, AE	-	-	4	0	4
207	Dharmais National Cancer Center Jakarta, ID	-	-	4	0	4
208	Duke Cancer Institute Durham, NC, US	-	1 · Trastuzumab emtansine	1	1	4
209	EMBL's European Bioinformatics Institute Hinxton, GB	-	-	4	0	4
210	European Society of Gynaecological Oncology Prague, CZ	-	-	4	0	4
211	European Society of Surgical Oncology Brussels, BE	-	-	4	0	4
212	Fundación Arturo López Pérez Santiago, CL	-	-	4	0	4
213	Garvan Institute of Medical Research / Kinghorn Cancer Centre Sydney, AU	-	-	4	0	4
214	Ghent University Hospital / Cancer Research Institute Ghent Ghent, BE	-	-	3	1	4
215	Great Ormond Street Hospital for Children London, GB	-	-	3	1	4
216	Groote Schuur Hospital / University of Cape Town Cape Town, ZA	-	-	4	0	4
217	HealthCare Global Enterprises Bengaluru, IN	-	-	4	0	4
218	Ho Chi Minh City Oncology Hospital Ho Chi Minh City, VN	-	-	4	0	4
219	Hokkaido University Hospital Sapporo, JP	-	-	4	0	4
220	Hospital Universitari i Politècnic La Fe Valencia, ES	-	-	4	0	4
221	HUS Comprehensive Cancer Center, Helsinki University Hospital Helsinki, FI	-	-	4	0	4
222	Institut National d'Oncologie, Rabat Rabat, MA	-	-	4	0	4
223	Institut Salah Azaïez Tunis, TN	-	-	4	0	4
224	Instituto Nacional de Câncer (INCA) Rio de Janeiro, BR	-	-	4	0	4
225	Instituto Nacional de Cancerología (Colombia) Bogotá, CO	-	-	4	0	4
226	Instituto Nacional de Enfermedades Neoplásicas Lima, PE	-	-	4	0	4
227	International Atomic Energy Agency: Rays of Hope Vienna, AT	-	-	4	0	4
228	Keio University Hospital Tokyo, JP	-	-	4	0	4
229	Koo Foundation Sun Yat-Sen Cancer Center Taipei, TW	-	-	4	0	4
230	Korle Bu Teaching Hospital Accra, GH	-	-	4	0	4
231	Maria Skłodowska-Curie National Research Institute of Oncology Warsaw, PL	-	-	4	0	4
232	Max Delbrück Center for Molecular Medicine Berlin, DE	-	-	4	0	4
233	National Cancer Institute, Cairo University Cairo, EG	-	-	4	0	4
234	National University Hospital / National University Cancer Institute, Singapore Singapore, SG	-	-	4	0	4
235	Ocean Road Cancer Institute Dar es Salaam, TZ	-	-	4	0	4
236	Olivia Newton-John Cancer Wellness and Research Centre Melbourne, AU	-	-	4	0	4
237	Prostate Cancer Foundation Santa Monica, CA, US	-	2 · Abiraterone acetate, Enzalutamide	0	0	4
238	QIMR Berghofer Medical Research Institute Brisbane, AU	-	-	3	1	4
239	Rajiv Gandhi Cancer Institute and Research Centre New Delhi, IN	-	-	4	0	4
240	Rigshospitalet, Copenhagen University Hospital Copenhagen, DK	-	-	4	0	4
241	Sahlgrenska University Hospital / Sahlgrenska Center for Cancer Research Gothenburg, SE	-	-	4	0	4
242	Samsung Medical Center Seoul, KR	-	-	4	0	4
243	Skåne University Hospital / Lund University Cancer Centre Lund, SE	-	-	4	0	4
244	Technion, Israel Institute of Technology Haifa, IL	-	1 · Bortezomib	2	0	4
245	Teenage Cancer Trust London, GB	-	-	4	0	4
246	The University of Kansas Cancer Center Kansas City, KS, US	-	-	4	0	4
247	Tianjin Medical University Cancer Institute and Hospital Tianjin, CN	-	-	4	0	4
248	Tohoku University Hospital Sendai, JP	-	-	3	1	4
249	Uganda Cancer Institute Kampala, UG	-	-	4	0	4
250	University Hospital Basel / Tumour Centre Basel, CH	-	-	4	0	4
251	USC Norris Comprehensive Cancer Center Los Angeles, CA, US	-	1 · Azacitidine	2	0	4
252	UVA Comprehensive Cancer Center Charlottesville, VA, US	-	-	4	0	4
253	Vietnam National Cancer Hospital (K Hospital) Hanoi, VN	-	-	4	0	4
254	Yale University Open Data Access (YODA) Project New Haven, CT, US	-	2 · Ciltacabtagene autoleucel, Teclistamab	0	0	4
255	Zhejiang Cancer Hospital Hangzhou, CN	-	-	4	0	4
256	Aberdeen Royal Infirmary Aberdeen, GB	1 · Precision-Panc	-	0	0	3
257	American Society of Clinical Oncology (ASCO) Alexandria, VA, US	1 · TAPUR	-	0	0	3
258	Breast Cancer Now London, GB	1 · TNT	-	0	0	3
259	Canadian Cancer Society Toronto, CA	1 · CHALLENGE	-	0	0	3
260	Castle Hill Hospital, Hull (Queen's Centre) Cottingham, GB	1 · Precision-Panc	-	0	0	3
261	Fondazione Michelangelo Milan, IT	1 · NeoTRIP	-	0	0	3
262	Instituto do Câncer do Estado de São Paulo (ICESP) São Paulo, BR	1 · Ivermectin plus losartan for COVID-19 in cancer patients	-	0	0	3
263	King's College Hospital, London London, GB	1 · Precision-Panc	-	0	0	3
264	Melanoma Institute Australia Sydney, AU	1 · COMBI-AD	-	0	0	3
265	Morriston Hospital, Swansea Swansea, GB	1 · EUROPAC	-	0	0	3
266	Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda Milan, IT	1 · HERACLES	-	0	0	3
267	Pancreatic Cancer UK London, GB	1 · EUROPAC	-	0	0	3
268	Princess Margaret Cancer Centre Toronto, CA	1 · CHALLENGE	-	0	0	3
269	Prostate Cancer UK London, GB	1 · TRANSFORM	-	0	0	3
270	Royal Free Hospital, Royal Free London NHS Foundation Trust London, GB	1 · Precision-Panc	-	0	0	3
271	Royal Papworth Hospital NHS Foundation Trust Cambridge, GB	1 · UKLS	-	0	0	3
272	Weston Park Cancer Centre, Sheffield Teaching Hospitals Sheffield, GB	1 · Precision-Panc	-	0	0	3
273	Wolfson Wohl Cancer Research Centre, University of Glasgow Glasgow, GB	1 · Precision-Panc	-	0	0	3
274	Advanced Research Projects Agency for Health Washington, DC, US	-	-	3	0	3
275	Aichi Cancer Center Nagoya, JP	-	-	1	2	3
276	American Society of Hematology Washington, DC, US	-	-	3	0	3
277	Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, NC, US	-	-	3	0	3
278	Breast Cancer Research Foundation New York, US	-	-	3	0	3
279	Broad Institute of MIT and Harvard Cambridge, MA, US	-	-	3	0	3
280	Cancer Care Alberta (Alberta Health Services) Calgary, AB, CA	-	-	3	0	3
281	Case Comprehensive Cancer Center Cleveland, OH, US	-	-	3	0	3
282	Centre Léon Bérard Lyon, FR	-	-	3	0	3
283	Centre Oscar Lambret Lille, FR	-	-	3	0	3
284	Chan Zuckerberg Biohub San Francisco, US	-	-	3	0	3
285	City of Hope Duarte, CA, US	-	-	3	0	3
286	Curanosticum Wiesbaden-Frankfurt Wiesbaden, DE	-	-	3	0	3
287	Edinburgh Cancer Centre / CRUK Scotland Centre Edinburgh, GB	-	-	3	0	3
288	European Hematology Association The Hague, NL	-	-	3	0	3
289	Fred Hutchinson Cancer Center Seattle, US	-	-	3	0	3
290	Geneva University Hospitals (HUG) Geneva, CH	-	-	3	0	3
291	German Cancer Research Center (DKFZ) Heidelberg, DE	-	-	3	0	3
292	Hacettepe University Cancer Institute Ankara, TR	-	-	3	0	3
293	Hamad Medical Corporation / National Center for Cancer Care and Research Doha, QA	-	-	3	0	3
294	Hospital de Amor (Barretos Cancer Hospital) Barretos, BR	-	-	3	0	3
295	Hospital de Clínicas de Porto Alegre Porto Alegre, BR	-	-	1	2	3
296	Hunan Cancer Hospital Changsha, CN	-	-	3	0	3
297	ICMR-National Institute of Cancer Prevention and Research Noida, IN	-	-	3	0	3
298	INCLIVA Biomedical Research Institute / Hospital Clínico Universitario de Valencia Valencia, ES	-	-	3	0	3
299	Institut Bergonié Bordeaux, FR	-	-	3	0	3
300	Institut Paoli-Calmettes Marseille, FR	-	-	3	0	3
301	Institut Pasteur Paris, FR	-	-	3	0	3
302	Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, CN	-	1 · Inaticabtagene autoleucel	1	0	3
303	Instituto Português de Oncologia de Lisboa Francisco Gentil Lisbon, PT	-	-	3	0	3
304	Istanbul University Institute of Oncology Istanbul, TR	-	-	3	0	3
305	Juravinski Cancer Centre / Escarpment Cancer Research Institute Hamilton, ON, CA	-	-	3	0	3
306	Kaiser Permanente Division of Research Oakland, CA, US	-	-	3	0	3
307	Kyushu University Hospital Fukuoka, JP	-	-	2	1	3
308	Lustgarten Foundation Woodbury, NY, US	-	-	3	0	3
309	Macmillan Cancer Support London, GB	-	-	3	0	3
310	Markey Cancer Center, University of Kentucky Lexington, KY, US	-	-	3	0	3
311	Masonic Cancer Center, University of Minnesota Minneapolis, MN, US	-	-	3	0	3
312	Max Healthcare (Max Institute of Cancer Care) New Delhi, IN	-	-	3	0	3
313	Mayo Clinic Comprehensive Cancer Center in Arizona Phoenix, AZ, US	-	-	3	0	3
314	Moffitt Cancer Center Tampa, FL, US	-	1 · Lifileucel	1	0	3
315	Movember Melbourne, AU	-	-	3	0	3
316	MUSC Hollings Cancer Center Charleston, SC, US	-	-	3	0	3
317	National Institute of Oncology, Hungary Budapest, HU	-	-	3	0	3
318	Nationwide Children's Hospital Columbus, OH, US	-	-	3	0	3
319	Osaka International Cancer Institute Osaka, JP	-	-	3	0	3
320	Peking Union Medical College Hospital Beijing, CN	-	-	3	0	3
321	Prince of Wales Hospital / Chinese University of Hong Kong Hong Kong, HK	-	-	3	0	3
322	QST Hospital (National Institutes for Quantum Science and Technology) Chiba, JP	-	-	3	0	3
323	Rambam Health Care Campus Haifa, IL	-	-	3	0	3
324	Rutgers Cancer Institute of New Jersey New Brunswick, NJ, US	-	-	3	0	3
325	Shaare Zedek Medical Center Jerusalem, IL	-	-	2	1	3
326	Sidney Kimmel Comprehensive Cancer Center at Jefferson Health Philadelphia, PA, US	-	-	2	1	3
327	Siriraj Hospital, Mahidol University Bangkok, TH	-	-	3	0	3
328	Sylvester Comprehensive Cancer Center, University of Miami Miami, FL, US	-	-	3	0	3
329	Tata Medical Center, Kolkata Kolkata, IN	-	-	3	0	3
330	Tel Aviv Sourasky Medical Center Tel Aviv, IL	-	-	3	0	3
331	Texas Children's Cancer and Hematology Center Houston, TX, US	-	-	2	1	3
332	The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool, GB	-	-	3	0	3
333	The Hospital for Sick Children (SickKids) Toronto, ON, CA	-	-	3	0	3
334	The Jackson Laboratory Cancer Center Bar Harbor, ME, US	-	-	3	0	3
335	The Wistar Institute Philadelphia, PA, US	-	-	2	1	3
336	University Cancer Center Frankfurt (UCT) Frankfurt am Main, DE	-	-	3	0	3
337	University of Malaya Medical Centre Kuala Lumpur, MY	-	-	2	1	3
338	University of Michigan Rogel Cancer Center Ann Arbor, MI, US	-	-	3	0	3
339	University of New Mexico Comprehensive Cancer Center Albuquerque, NM, US	-	-	3	0	3
340	ANCHOR Centre, Aberdeen Royal Infirmary Aberdeen, GB	-	1 · Mia	0	0	2
341	Arc Institute Palo Alto, CA, US	-	-	2	0	2
342	Auckland City Hospital / Te Pūriri o Te Ora Cancer and Blood Service Auckland, NZ	-	-	2	0	2
343	Barbara Ann Karmanos Cancer Institute Detroit, MI, US	-	-	1	1	2
344	Cancer Center at Illinois Urbana, IL, US	-	-	2	0	2
345	Cancer Institute of Iran, Imam Khomeini Hospital Complex Tehran, IR	-	-	2	0	2
346	Catalan Institute of Oncology (ICO) L'Hospitalet de Llobregat, ES	-	-	2	0	2
347	Chao Family Comprehensive Cancer Center, UC Irvine Orange, CA, US	-	-	2	0	2
348	City of Hope Orange County Irvine, CA, US	-	-	2	0	2
349	Cold Spring Harbor Laboratory Cold Spring Harbor, NY, US	-	-	2	0	2
350	European Medicines Agency Amsterdam, NL	-	-	2	0	2
351	European Society for Clinical Nutrition and Metabolism Luxembourg, LU	-	-	2	0	2
352	Excel Diagnostics and Nuclear Oncology Center Houston, US	-	-	2	0	2
353	First Affiliated Hospital of Sun Yat-sen University Guangzhou, CN	-	-	2	0	2
354	Fox Chase Cancer Center Philadelphia, PA, US	-	-	1	1	2
355	Fred & Pamela Buffett Cancer Center Omaha, NE, US	-	-	2	0	2
356	German Cancer Consortium (DKTK) Heidelberg, DE	-	-	2	0	2
357	Gunma University Heavy Ion Medical Center Maebashi, JP	-	-	2	0	2
358	Hebrew University of Jerusalem Jerusalem, IL	-	1 · Pegylated liposomal doxorubicin	0	0	2
359	Henan Cancer Hospital Zhengzhou, CN	-	-	2	0	2
360	Indian Institute of Science Bengaluru, IN	-	-	2	0	2
361	Institut Curie Paris, FR	-	-	2	0	2
362	Institute for Stem Cell Science and Regenerative Medicine Bengaluru, IN	-	-	2	0	2
363	Japanese Society of Medical Oncology Tokyo, JP	-	-	2	0	2
364	Kidwai Memorial Institute of Oncology Bengaluru, IN	-	-	2	0	2
365	Ludwig Cancer Research New York, US	-	-	2	0	2
366	Maastricht UMC+ Comprehensive Cancer Center Maastricht, NL	-	-	2	0	2
367	Medicines and Healthcare products Regulatory Agency London, GB	-	-	2	0	2
368	National Cancer Grid of India Mumbai, IN	-	-	2	0	2
369	New York Proton Center New York, US	-	-	2	0	2
370	Ontario Institute for Cancer Research Toronto, ON, CA	-	-	2	0	2
371	Parker Institute for Cancer Immunotherapy San Francisco, US	-	-	2	0	2
372	Peking University People's Hospital Beijing, CN	-	-	2	0	2
373	Philippine General Hospital Manila, PH	-	-	2	0	2
374	Queen Mary Hospital / University of Hong Kong Hong Kong, HK	-	-	2	0	2
375	Ramathibodi Hospital, Mahidol University Bangkok, TH	-	-	2	0	2
376	Royal Adelaide Hospital Adelaide, AU	-	-	2	0	2
377	Salk Institute Cancer Center La Jolla, CA, US	-	-	2	0	2
378	Sanford Burnham Prebys Medical Discovery Institute La Jolla, CA, US	-	-	2	0	2
379	Seoul National University Hospital Seoul, KR	-	-	2	0	2
380	Tawam Hospital Al Ain, AE	-	-	2	0	2
381	Tel Aviv University Tel Aviv, IL	-	-	2	0	2
382	The Ottawa Hospital Cancer Centre / Ottawa Hospital Research Institute Ottawa, ON, CA	-	-	2	0	2
383	UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC, US	-	-	2	0	2
384	University Medical Center Groningen Comprehensive Cancer Center Groningen, NL	-	-	2	0	2
385	Wellcome London, GB	-	-	2	0	2
386	Wilmot Cancer Institute, University of Rochester Rochester, NY, US	-	-	2	0	2
387	World Health Organization Cancer Programme Geneva, CH	-	-	2	0	2
388	Asthra Health Santa Monica, US	-	-	1	0	1
389	Cancer Research UK City of London Centre London, GB	-	-	1	0	1
390	CeCurio (MVZ Tübingen oncology) Tübingen, DE	-	-	1	0	1
391	Centre François Baclesse Caen, FR	-	-	1	0	1
392	Centre Jean Perrin Clermont-Ferrand, FR	-	-	1	0	1
393	Cheshire and Merseyside Cancer Alliance Liverpool, GB	-	-	1	0	1
394	Docrates Cancer Center Helsinki, FI	-	-	1	0	1
395	East Midlands Cancer Alliance Nottingham, GB	-	-	1	0	1
396	East of England Cancer Alliance Cambridge, GB	-	-	1	0	1
397	European Cancer Organisation Brussels, BE	-	-	1	0	1
398	Fondazione IRCCS Istituto Nazionale dei Tumori Milan, IT	-	-	1	0	1
399	Gates Foundation Seattle, WA, US	-	-	1	0	1
400	Greater Manchester Cancer Alliance Manchester, GB	-	-	1	0	1
401	HL7 International Ann Arbor, MI, US	-	-	1	0	1
402	Hôpital Maisonneuve-Rosemont / CIUSSS de l'Est-de-l'Île-de-Montréal Montréal, CA	-	-	1	0	1
403	Houston Methodist Center for RNA Therapeutics Houston, US	-	-	1	0	1
404	Howard Hughes Medical Institute Chevy Chase, MD, US	-	-	1	0	1
405	Humber & North Yorkshire Cancer Alliance Hull, GB	-	-	1	0	1
406	Immunocine Cancún, MX	-	-	1	0	1
407	Indian Council of Medical Research New Delhi, IN	-	-	1	0	1
408	Institut de Cancérologie de l'Ouest (ICO) Angers, FR	-	-	1	0	1
409	Institut du Cancer de Montpellier (ICM) Montpellier, FR	-	-	1	0	1
410	Institut du Cancer Paris CARPEM, AP-HP Centre Paris, FR	-	-	1	0	1
411	Institute for Protein Design (University of Washington) Seattle, US	-	-	1	0	1
412	Instituto Nacional de Oncología y Radiobiología (INOR) Havana, CU	-	-	0	1	1
413	Intermountain Health Cancer Center Salt Lake City, UT, US	-	-	1	0	1
414	IRCCS Sacro Cuore Don Calabria Hospital Negrar di Valpolicella (Verona), IT	-	-	1	0	1
415	Kent and Medway Cancer Alliance Maidstone, GB	-	-	1	0	1
416	Lancashire and South Cumbria Cancer Alliance Preston, GB	-	-	1	0	1
417	Li Ka Shing Foundation Hong Kong, HK	-	-	1	0	1
418	Melanoma Research Alliance Washington, DC, US	-	-	1	0	1
419	National Cancer Registry Programme (ICMR-NINE, Bengaluru) Bengaluru, IN	-	-	1	0	1
420	National Health Authority (Ayushman Bharat PM-JAY) New Delhi, IN	-	-	1	0	1
421	National Institute for Health and Care Excellence London, GB	-	-	1	0	1
422	North Central London Cancer Alliance London, GB	-	-	1	0	1
423	North East London Cancer Alliance London, GB	-	-	1	0	1
424	Northern Cancer Alliance Newcastle upon Tyne, GB	-	-	1	0	1
425	Northwell Health Cancer Institute New Hyde Park, NY, US	-	-	1	0	1
426	O'Neal Comprehensive Cancer Center at UAB Birmingham, AL, US	-	-	1	0	1
427	OncoZON Comprehensive Cancer Network Maastricht, NL	-	-	1	0	1
428	Paul-Ehrlich-Institut Langen, DE	-	-	1	0	1
429	Peninsula Cancer Alliance Exeter, GB	-	-	1	0	1
430	Providence Health & Services Renton, WA, US	-	-	1	0	1
431	Radboudumc Centre for Oncology Nijmegen, NL	-	-	1	0	1
432	Roswell Park Comprehensive Cancer Center Buffalo, NY, US	-	-	1	0	1
433	Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Bristol, GB	-	-	1	0	1
434	South East London Cancer Alliance London, GB	-	-	1	0	1
435	South Yorkshire and Bassetlaw Cancer Alliance Sheffield, GB	-	-	1	0	1
436	Steve Biko Academic Hospital / University of Pretoria Pretoria, ZA	-	-	1	0	1
437	Surrey and Sussex Cancer Alliance Guildford, GB	-	-	1	0	1
438	Terry Fox Research Institute Vancouver, CA	-	-	1	0	1
439	Thames Valley Cancer Alliance Oxford, GB	-	-	1	0	1
440	The new AIIMS network (PMSSY) New Delhi, IN	-	-	1	0	1
441	Therapeutic Goods Administration Canberra, AU	-	-	1	0	1
442	Trinity St James's Cancer Institute Dublin, IE	-	-	1	0	1
443	Turku University Hospital Cancer Centre Turku, FI	-	-	1	0	1
444	University of Arizona Cancer Center Tucson, AZ, US	-	-	1	0	1
445	Verspeeten Family Cancer Centre, London Health Sciences Centre London, ON, CA	-	-	1	0	1
446	Wessex Cancer Alliance Southampton, GB	-	-	1	0	1
447	West Midlands Cancer Alliance Birmingham, GB	-	-	1	0	1
448	West Yorkshire and Harrogate Cancer Alliance Leeds, GB	-	-	1	0	1
449	Yale School of Medicine / Yale Cancer Center New Haven, CT, US	-	-	1	0	1
450	Zentrum für Krebsregisterdaten am Robert Koch-Institut Berlin, DE	-	-	1	0	1